drugset / Trial / NCT01162928

Parenteral Nutrition With Intravenous and Oral Fish Oil for Intensive Care Patients

NCT01162928 ↗

Phase 3 Completed 100 enrolled B. Braun Melsungen AG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to assess the effect of fish oil-enriched enteral and parenteral nutrition on blood oxygenation in critically ill patients.

Timeline

Start
2013-05
Primary completion
2017-11
Completion
2017-11

Outcome

Missed primary endpoint

paper Blood oxygenation (ΔPaO2/FiO2 from D1 to D4: -1.3 ± 83.7, n = 42, and 13.3 ± 86.1, n = 39, in omega-3 and control group, respectively, p = 0.7795 PMID 33932802 ↗

paper Enteral and supplemental PN both enriched with omega-3 PUFA did not improve lung function PMID 33932802 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nutriflex Lipid special Unknown — —
Subject Nutriflex Omega special Unknown — —
Subject Oxepa Unknown — —
Comparator Pulmocare Unknown — —

Indications

No indication recorded.